DTC Internet ads
This article was originally published in The Tan Sheet
Executive Summary
FDA's Division of Drug Marketing, Advertising and Communication will issue a guidance on Internet promotions of prescription drugs shortly, DDMAC Director Minnie Baylor-Henry notes at the Drug Information Association annual meeting in Boston June 10. Without discussing the guidance specifically, Baylor-Henry indicates promotions that would be deemed violative for press releases would be considered similarly misleading on the Web. FDA is exploring "multiple remedies" for violative DTC promos, Baylor-Henry says, including warning letters, consent decrees, seizures and criminal prosecution. She also cautions companies against allowing their promotions departments to test the limits of legal DTC ads, advising that firms not use DDMAC "as a quality assurance checkpoint"...